99 related articles for article (PubMed ID: 26739330)
1. Association of liprin β-1 with kank proteins in melanoma.
Luo M; Mengos AE; Mandarino LJ; Sekulic A
Exp Dermatol; 2016 Apr; 25(4):321-3. PubMed ID: 26739330
[No Abstract] [Full Text] [Related]
2. Structural basis for the recognition of kinesin family member 21A (KIF21A) by the ankyrin domains of KANK1 and KANK2 proteins.
Guo Q; Liao S; Zhu Z; Li Y; Li F; Xu C
J Biol Chem; 2018 Jan; 293(2):557-566. PubMed ID: 29183992
[TBL] [Abstract][Full Text] [Related]
3. Expression and significance of p53, rb, p21/waf-1, p16/ink-4a, and PTEN tumor suppressors in canine melanoma.
Koenig A; Bianco SR; Fosmire S; Wojcieszyn J; Modiano JF
Vet Pathol; 2002 Jul; 39(4):458-72. PubMed ID: 12126149
[TBL] [Abstract][Full Text] [Related]
4. Inhibitor of growth 4 suppresses cell spreading and cell migration by interacting with a novel binding partner, liprin alpha1.
Shen JC; Unoki M; Ythier D; Duperray A; Varticovski L; Kumamoto K; Pedeux R; Harris CC
Cancer Res; 2007 Mar; 67(6):2552-8. PubMed ID: 17363573
[TBL] [Abstract][Full Text] [Related]
5. RAB27A/Melanophilin Blocker Inhibits Melanoma Cell Motility and Invasion.
Guo D; Jain R; Hwang JS; Weninger W; Beaumont KA; Tikoo S
J Invest Dermatol; 2020 Jul; 140(7):1470-1473.e3. PubMed ID: 31978414
[No Abstract] [Full Text] [Related]
6. Talin2 and KANK2 functionally interact to regulate microtubule dynamics, paclitaxel sensitivity and cell migration in the MDA-MB-435S melanoma cell line.
Lončarić M; Stojanović N; Rac-Justament A; Coopmans K; Majhen D; Humphries JD; Humphries MJ; Ambriović-Ristov A
Cell Mol Biol Lett; 2023 Jul; 28(1):56. PubMed ID: 37460977
[TBL] [Abstract][Full Text] [Related]
7. miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells.
Dynoodt P; Speeckaert R; De Wever O; Chevolet I; Brochez L; Lambert J; Van Gele M
Int J Oncol; 2013 Apr; 42(4):1443-51. PubMed ID: 23404256
[TBL] [Abstract][Full Text] [Related]
8. Use of human tissue to assess the oncogenic activity of melanoma-associated mutations.
Chudnovsky Y; Adams AE; Robbins PB; Lin Q; Khavari PA
Nat Genet; 2005 Jul; 37(7):745-9. PubMed ID: 15951821
[TBL] [Abstract][Full Text] [Related]
9. The KISS1 metastasis suppressor: mechanistic insights and clinical utility.
Nash KT; Welch DR
Front Biosci; 2006 Jan; 11():647-59. PubMed ID: 16146758
[TBL] [Abstract][Full Text] [Related]
10. KANK family proteins in cancer.
Tadijan A; Samaržija I; Humphries JD; Humphries MJ; Ambriović-Ristov A
Int J Biochem Cell Biol; 2021 Feb; 131():105903. PubMed ID: 33309958
[TBL] [Abstract][Full Text] [Related]
11. Microphthalmia-associated transcription factor regulates skin melanoblast migration by repressing the melanoma cell adhesion molecule.
Rao C; Su Z; Li H; Ma X; Zheng X; Liu Y; Lu F; Qu J; Hou L
Exp Dermatol; 2016 Jan; 25(1):74-6. PubMed ID: 26284703
[No Abstract] [Full Text] [Related]
12. RASSF8 regulates progression of cutaneous melanoma through nuclear factor-κb.
Wang J; Hua W; Huang SK; Fan K; Takeshima L; Mao Y; Hoon DS
Oncotarget; 2015 Oct; 6(30):30165-77. PubMed ID: 26334503
[TBL] [Abstract][Full Text] [Related]
13. Proteomic profiling of human melanoma metastatic cell line secretomes.
Rocco M; Malorni L; Cozzolino R; Palmieri G; Rozzo C; Manca A; Parente A; Chambery A
J Proteome Res; 2011 Oct; 10(10):4703-14. PubMed ID: 21815687
[TBL] [Abstract][Full Text] [Related]
14. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression.
Reed JA; Loganzo F; Shea CR; Walker GJ; Flores JF; Glendening JM; Bogdany JK; Shiel MJ; Haluska FG; Fountain JW
Cancer Res; 1995 Jul; 55(13):2713-8. PubMed ID: 7796391
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of cylindromatosis gene, CYLD, confers a growth advantage on malignant melanoma cells while negatively regulating their migration activity.
Ishikawa Y; Tsunoda K; Shibazaki M; Takahashi K; Akasaka T; Masuda T; Maesawa C
Int J Oncol; 2012 Jul; 41(1):53-60. PubMed ID: 22469839
[TBL] [Abstract][Full Text] [Related]
16. Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.
Tsao H; Goel V; Wu H; Yang G; Haluska FG
J Invest Dermatol; 2004 Feb; 122(2):337-41. PubMed ID: 15009714
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of human angiotropic primary melanoma: selection of 15 differentially expressed genes potentially involved in extravascular migratory metastasis.
Lugassy C; Lazar V; Dessen P; van den Oord JJ; Winnepenninckx V; Spatz A; Bagot M; Bensussan A; Janin A; Eggermont AM; Barnhill RL
Eur J Cancer; 2011 May; 47(8):1267-75. PubMed ID: 21334873
[TBL] [Abstract][Full Text] [Related]
18. Lin28B promotes melanoma growth by mediating a microRNA regulatory circuit.
Zhang Z; Zhang S; Ma P; Jing Y; Peng H; Gao WQ; Zhuang G
Carcinogenesis; 2015 Sep; 36(9):937-45. PubMed ID: 26071398
[TBL] [Abstract][Full Text] [Related]
19. Interaction of extracellular S100A4 with RAGE prompts prometastatic activation of A375 melanoma cells.
Herwig N; Belter B; Wolf S; Haase-Kohn C; Pietzsch J
J Cell Mol Med; 2016 May; 20(5):825-35. PubMed ID: 26928771
[TBL] [Abstract][Full Text] [Related]
20. A novel role for microphthalmia-associated transcription factor-regulated pigment epithelium-derived factor during melanoma progression.
Dadras SS; Lin RJ; Razavi G; Kawakami A; Du J; Feige E; Milner DA; Loda MF; Granter SR; Detmar M; Widlund HR; Horstmann MA; Fisher DE
Am J Pathol; 2015 Jan; 185(1):252-65. PubMed ID: 25447045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
